7 of the Best Penny Stocks to Buy Coming Into Year-End

penny stocks - 7 of the Best Penny Stocks to Buy Coming Into Year-End

Source: John Brueske/Shutterstock.com

Even though some penny stocks have multi-bagger potential, they’re incredibly risky. The companies behind them typically haven’t had much experience in the marketplace. However, well-known companies may also fall under this category if their shares have plummeted. With proper due diligence and diversification, penny stocks could add a lot of value to your portfolios.

Penny stocks are typically those shares which are trading below the $5 mark. They tend to be inherently riskier than large-cap companies. However, if picked wisely, they have the potential to provide big gains.

August was a great month for penny stocks, including those popular on social media sites. With higher volatility across all markets as well as lower interest rates, investors should scoop up some penny stocks. Here are seven that can break out by the close of this year:

  • eMagin Corporation (NYSEAMERICAN:EMAN)
  • Boxlight Corporation (NASDAQ:BOXL)
  • Exela Technologies (NASDAQ:XELA)
  • Mind Medicine (NASDAQ:MNMD)
  • Biocept Inc. (NASDAQ:BIOC)
  • Ebang International (NASDAQ:EBON)
  • Ucore Rare Metals Inc (OTCMKTS:UURAF)

Penny Stocks: eMagin Corporation (EMAN)

EMAN stock: a concept image of OLED with blue and purple lights
Source: silvae / Shutterstock

eMagin Corporation is a U.S.-based organic light-emitting diode (OLED) microdisplay manufacturer. Its patented red-green-blue Direct Patterning (dPd) technology provides a competitive edge over its peers.

The company produces OLED displays with significantly higher brightness and resolution. Display brightness is a key differentiator among companies in this sphere, so eMagin is a clear leader in the sector.

The OLED industry is set to grow at a healthy 13.6% annual rate from 2021 to 2026. One of the key catalysts in this expansion will be demand for OLED tech in smartphones, augmented reality (AR) and virtual reality (VR).

EMAN stock and its peers have an exciting opportunity ahead of them. However, the company needs to strike a long-term licensing agreement to attract large-scale customers that will stick around.

Boxlight Corporation (BOXL)

Boxlight (BOXL) website under magnifying glass
Source: Pavel Kapysh / Shutterstock.com

Boxlight Corporation produces and sells interactive classroom solutions, primarily targeting the K-12 market. It develops various education technology products, including interactive projectors, touch boards and assessment systems.

After a few quarters of being hampered by pandemic-induced weakness, Boxlight is back with a bang, posting stellar top-line results.

The company experienced triple-digit growth in its revenues on a year-over-year (YOY) basis in the past three quarters. Revenues in the second quarter grew to $46.8 million, representing a massive 497% increase from the prior year’s quarter. Additionally, customer orders rose by a colossal 986% to $76 million.

It appears the acquisition of U.K.-based Sahara Presentation Systems has been somewhat of a gamechanger for BOXL stock. It expects its third-quarter revenue to come in at $60 million, a considerable increase compared to Q2.

Penny Stocks: Exela Technologies (XELA)

A man examines a digital screen with different icons for software.
Source: Shutterstock

Exela Technologies offers business process automation services to customers around the world. Its diversified software solutions enable clients to execute their digital transformation strategies effectively.

The company’s wide variety of offerings cover dozens of industries, providing everything from discrete services to end-to-end processes. Therefore, Exela has the potential to ramp up its sales and free cash flows by a significant margin in the coming years.

The transition to its digital strategy and pandemic-related challenges have negatively impacted Exela’s earnings performance. However, as the operating environment normalizes, things might get easier for the company.

Its massive debt load is a problem for XELA stock, which is why it needs to continue to perform well and generate significant free cash flows. But once it addresses this issue, Exela shares can take off.

Mind Medicine (MNMD)

MNMD stock: A scientist holding a test tube in a stock image
Source: Shutterstock

Mind Medicine is a biotechnology company that develops psychedelic-inspired medicines. We have seen a growing acceptance for these treatments of late, leaving companies such as Mind Medicine in a great position to succeed.

The psychedelic drug industry is still in its nascent stage, so there is a considerable amount of risk to investing in the arena. That being said, MNMD stock presents an exciting long-term opportunity and is an attractive buy at current levels.

Mind Medicine currently has a healthy pipeline of potential therapies which cater to several ailments. All of them are currently in trial phases but present a huge long-term revenue stream for the company.

The psychedelic drugs market is expected to rise at a compound annual growth rate (CAGR) of 13.3% from 2021 to 2028. The growing market size stems from the increasing prevalence of mental health concerns such as anxiety and depression. Therefore, MNMD stock has a massive growth runway ahead of it.

Penny Stocks: Biocept Inc. (BIOC)

Image of two scientists in lab coats studying results in a lab
Source: Shutterstock

Biocept Inc. is a biotechnology company that specializes in molecular oncology diagnostics. It develops and commercializes proprietary tumor cells and tumor nucleic acid assays. This gives healthcare providers valuable information to give targeted therapy to cancer patients.

The company also develops polymerase chain reaction (PCR)-based assays to detect the novel coronavirus. Biocept has partnered with Cleared4 for tracking and testing requirements for the virus.

Biocept has recently exceled on the earnings front. Revenue growth has been staggering in the past three quarters, mainly due to the extraordinary influx of Covid 19 test samples. For instance, its second-quarter revenues were at $12 million, representing YOY growth of more than 1,200%.

The company partnered with Quest Diagnostics (NYSE:DGX) to provide liquid biopsy testing for lung cancer patients. Hence, BIOC stock has immense potential to provide hefty returns for its investors in the long run.

Ebang International (EBON)

A photo showing the website of Ebang (EBON) on a browser.
Source: Jarretera / Shutterstock.com

Ebang International is a provider of ASIC chip design and high-performance Bitcoin mining equipment. The blockchain company has 51 registered patents, 56 software copyrights and seven IC layout designs.

It derives most of its revenues from the sale of Bitcoin mining machines. Hence, its business is heavily dependent upon the price of the cryptocurrency.

Bitcoin has risen more than 46% in value since the start of the year, but has swung wildly in the process. The crypto has cooled considerably after a historic year.

However, if Bitcoin can gather momentum in the coming months, it will likely push EBON stock higher. At this point, though, Ebang is only a short-term investment.

Ucore Rare Metals Inc (UURAF)

UURAF stock: a close up shot of a pile of rare earth metals
Source: Joaquin Corbalan P / Shutterstock

Ucore Rare Metals is a company involved in the exploration and separation of rare earth elements in the North American region. It claims to be committed to socially and environmentally responsible practices.

The company holds a 100% interest in Bokan Mountain and Dotson Ridge, located in Alaska.

Ucore has also entered an agreement with a partner of Hexagon, another rare earth metal company, to assess its separation tech. Known as Rapid SX, the extraction technique separates rare earth elements more quickly than traditional approaches.

The process has industry insiders buzzing about the company. Ucore says it is a significantly faster, cheaper and more robust method of extracting rare earth elements. Therefore, UURAF stock could be a long-term winner if its technology can live up to its billing.

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.

Read More:Penny Stocks — How to Profit Without Getting Scammed

On the date of publication, Muslim Farooque did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Muslim Farooque is a keen investor and an optimist at heart. A life-long gamer and tech enthusiast, he has a particular affinity for analyzing technology stocks. Muslim holds a bachelor’s of science degree in applied accounting from Oxford Brookes University. 


Article printed from InvestorPlace Media, https://investorplace.com/2021/09/7-of-the-best-penny-stocks-to-buy-coming-into-year-end/.

©2021 InvestorPlace Media, LLC